NewsRoom Articles - Page 86 of 154 - PsychedelicNewsWire (PNW)

FridaySep 03, 2021 2:00 pm

Bill to Legalize Psychedelics Possession in California Paused

A measure to legalize the possession of psychedelics such as ayahuasca and psilocybin in the state of California will not be advancing this session. The temporary halt to the bill occured after its sponsor decided that more time was needed to compile additional evidence for reform in order to solidify the bill’s chances of being passed. The bill, which had already been cleared in the Senate, will be made into a two-year legislation, which means it will not be advanced to the floor until 2022. The legislation was sponsored by Sen. Scott Wiener, who has spent a lot of time…

ThursdaySep 02, 2021 2:00 pm

Grand Rapids One Step Closer to Decriminalizing Entheogenic Plants, Fungi

The city of Grand Rapids, Michigan, may soon deprioritize the enforcement of laws against the use, growing and possession of entheogenic fungi and plants. Grand Rapids city commissioner Kurt Reppart stated that, while this wouldn’t decriminalize the psychedelics, it would allow individuals to gift, grow, use or possess psychedelics without facing any legal charges. Reppart is in favor of making psychedelics the lowest priority for the city’s law enforcement and believes that the move will not only acknowledge that these fungi and plants can not only be medicines for individuals using them to treat conditions such as anxiety, depression, addiction…

WednesdaySep 01, 2021 3:50 pm

Filmmaker Behind Netflix’s Psychedelics Documentary Is Working on Sequel

If you’re interested in psychedelics and have watched the “Adventures in Psychedelics” documentary on Netflix, you may soon be getting a sequel. The documentary’s writer, Donick Cary, recently revealed that a series or film — or both — is on the horizon, hinting at the possibility of a podcast as well. The “Adventures in Psychedelics” documentary first aired on Netflix in May 2020. However, it took more than a decade to make, with Mike Rosenstein, who was the producer, and Cary interviewing celebrities such as Anthony Bourdain, A$AP Rocky and Carrie Fisher about their experiences with psychedelics. This documentary, which…

TuesdayAug 31, 2021 2:00 pm

University of Wisconsin-Madison Launches Psychedelics Research Center

At the start of the week, the School of Pharmacy at the University of Wisconsin-Madison unveiled its psychedelics center, named the Transdisciplinary Center for Research in Psychoactive Substances. Researchers will investigate the therapeutic potential of psychedelics like MDMA and psilocybin in treating conditions such as opioid addiction, major depressive disorder and post-traumatic stress disorder. In addition to this, the center will also offer educational training for psychedelics practitioners and scientists. In its press release, the department asserted that the institute would work to consider diversity participants used in research, noting that people of color were often underrepresented in psychedelics studies.…

MondayAug 30, 2021 2:30 pm

Study Finds That Most Mental Health Service Users Support Psychedelics Research

A study that was recently published in the “Irish Journal of Medical Science” has found that individuals who use mental health services in Ireland favorably view research on psychedelics. The study found that more than half of its participants were willing to try psychedelic therapy if their physicians recommended it. However, the study also found evidence of therapeutic misalignment as the symptoms of some individuals who suffer from mental health disorders could be worsened by psychedelics. For the study, the researchers conducted a survey that assessed the attitudes of individuals who suffered from mental health diseases towards psilocybin therapy and…

MondayAug 30, 2021 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Applications to Support Research Phase Programs, Strengthen IP Portfolio

Company’s nonprovisional patent application includes claims to compositions, methods to support certain elements of preclinical and research programs Two international patent applications will grant Cybin the right to file future national applications into treaty member jurisdictions Cybin portfolio consists of 14 patent filings, 50-plus proprietary molecules, 50-plus preclinical studies and 4 active drug programs Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, is moving forward to progress and strengthen its IP portfolio by filing three patents this month. After receiving an international search report of its May 2021 Patent Cooperation Treaty (“PCT”) application, Cybin…

FridayAug 27, 2021 1:32 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), At the Forefront of the Psychedelic Renaissance

Psychedelics date back to ancient times, with records showing their use among the Aztecs as well as cultures in North Africa and Europe for medicinal and cultural purposes The prohibition era marked significant strides in psychedelics research, including the ultimate prohibition of the possession, sale and manufacture of psychedelics The 21st century has seen a surge in psychedelics research, a critical factor that has initiated a renaissance in this industry Tryp Therapeutics remains at the forefront of this renaissance with its commitment to identifying and developing clinical-stage compounds for diseases with high unmet medical needs, like Fibromyalgia and Eating Disorder…

FridayAug 27, 2021 1:30 pm

Portland Activists Call for Psychedelics to Be Decriminalized

Activists in Portland are calling for the city commission to approve a measure that would decriminalize the ceremonial use, gifting and growing of a number of psychedelics. This new measure would make community-based ceremonies and activities that involve entheogenic substances such as ibogaine and ayahuasca among the lowest law-enforcement priorities in Portland, Oregon. The activists, who are part of the PMHA (Plant Medicine Healing Alliance), worked with indigenous groups to draw up the initiative. This is why DMT extracted from toads and peyote were excluded from the initiative because of sustainability concerns. According to an overview, the draft initiative would…

ThursdayAug 26, 2021 1:50 pm

What To Know Before Investing in the Psychedelic Industry

The burgeoning marijuana industry has presented numerous investment opportunities for individuals and companies alike. The psychedelic drug market, which is still immature, seems to be following this trend, with projections showing that its market size will have reached almost $11 billion by 2027. Most analysts agreewith a capital markets analyst from Canaccord Genuity, who estimates that psychedelic substances such as LSD and psilocybin could create an investment opportunity worth nearly $100 billion. Data from the CDC shows that the number of Americans suffering from suicidal thoughts, depression and anxiety almost doubled during the coronavirus pandemic. Numerous studies have also shown…

WednesdayAug 25, 2021 12:45 pm

Psychedelic Clinical Trials in Europe to Advance Through Partnership with CROs

A new dawn in psychedelic research seems to be upon the pharmaceutical industry as we are witnessing partnerships between drug-development companies and contract research organizations. The partnerships are intended to speed up the drug-development process. For example, a partnership between Transpharmation and Clerkenwell Health will facilitate the advancement of psychedelic research in Europe as it will enable both clinical and preclinical trials to run simultaneously. It will also offer opportunities to drug developers working to bring psychedelic-inspired drugs to the market. In addition, such partnerships will provide coordinated and integrated methodology and support for every stage of psychedelic research. The…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000